UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June
2025
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
03 June
2025- “Director/PDMR Shareholding”
|
99.1
Haleon plc: Director/PDMR
Shareholding
3 June 2025: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces
notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by
Persons Discharging Managerial Responsibilities
("PDMRs").
On 2 June 2025, Ed Petter, Chief Corporate Affairs Officer,
received the vesting of the first tranche of an award of Haleon
Ordinary Shares under the Haleon Share Value Plan. The award was
granted as part of his remuneration arrangements upon joining
Haleon, to compensate for forfeited incentives from his previous
employment.
The award is subject to malus and clawback provisions.
Further details are set out in the below notification, made in
accordance with the requirements of The UK Market Abuse
Regulations.
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
|
a)
|
Name
|
Ed
Petter
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
Chief
Corporate Affairs Officer
|
|
|
b)
|
Initial notification /Amendment
|
Initial
Notification
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
||
|
a)
|
Name
|
Haleon
plc
|
|
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares in respect of the first vesting of
the Haleon plc Share Value Plan (Buyout award).
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
Nil
|
51,584
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
2 June 2025
|
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of £0.01 each
GB00BMX86B70
|
|
|
b)
|
Nature of the transaction
|
Automatic disposal of Ordinary Shares resulting from Haleon plc
Share Value Plan (Buyout award) vesting to cover tax
liabilities.
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£4.134623
|
24,305.243108
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
2 June 2025
|
|
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with
a purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans six major categories - Oral Health,
Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory
Health, Digestive Health and Therapeutic Skin Health and Other. Its
long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne,
Theraflu and Voltaren - are built on trusted science, innovation
and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date: June 03,
2025
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|